This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Beijing Hanmi Pharm. Co., Ltd.. Active years: 2021-2023.
Location History:
- Beijing, CN (2021)
- Shunyi District, CN (2023)
Company Filing History:
Years Active: 2021-2023
Title: The Innovations of Mengxie Jin
Introduction
Mengxie Jin is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. With a total of 3 patents to his name, Jin's work is paving the way for advancements in complex disease treatments.
Latest Patents
Among his latest patents is the "Anti-PD-L1/anti-PD-1 natural antibody structure-like heterodimeric bispecific antibody and preparation thereof." This invention provides a highly stable heterodimeric bispecific antibody that mimics the characteristics of a natural IgG, ensuring no mismatches between heavy and light chains. This innovative antibody can effectively bind to both PD-L1 and PD-1 target molecules, enhancing treatment efficacy for complex diseases. Another notable patent is the "Antibody specifically binding to PD-1 and functional fragment thereof," which includes both PD-1 chimeric and humanized antibodies, along with their functional fragments.
Career Highlights
Mengxie Jin has worked with notable companies such as Beijing Hanmi Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise in antibody development and therapeutic applications.
Collaborations
Throughout his career, Jin has collaborated with esteemed colleagues, including Yaping Yang and Jiawang Liu. These partnerships have contributed to the success of his innovative projects.
Conclusion
Mengxie Jin's contributions to the field of biotechnology through his patents and collaborations highlight his role as a leading inventor. His work continues to influence the development of effective treatments for complex diseases.